Skip to main content
Filing year 2024

THE NEUROBLASTOMA CHILDRENS CANCER SOCIETY

Schaumburg, Illinois·EIN 36-3969321·NTEE H30 · Medical Research·3
Total revenue
$30k
Total assets
$27k
Total expenses
$34k
Reported officers
5
Mission

PROVIDE GRANTS FOR NEUROBLASTOMA AND RELATED CHILDREN'S CANCER RESEARCH AND PROVIDE SUPPORT TO PARENTS AND FAMILIES WITH CHILDREN DIAGNOSED WITH CHILDREN'S CANCER.

Reported officers (all unpaid)

No paid executives reported in 2024. THE NEUROBLASTOMA CHILDRENS CANCER SOCIETY reported 5 unpaid officers and board members on its 990.

Director
Executive Di
Director
President
Chairman
Financial trend

Revenue and expenses over time

THE NEUROBLASTOMA CHILDRENS CANCER SOCIETY reported revenue and expenses across 3 filing years.

RevenueExpenses
$30k
$39k
2022
$23k
$33k
2023
$30k
$34k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn

THE NEUROBLASTOMA CHILDRENS CANCER SOCIETY reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $114,840.

25th percentile
$40k
Median
$114,840
75th percentile
$234k
90th percentile
$424k

These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).

See full Medical Research compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.